Collegium Pharmaceutical, Inc.

Healthcare

NASDAQ:COLL · NASDAQ Global Select

Market Cap $1.12B Beta 0.75 P/E (TTM) 14.8

$34.64 +0.87%

+$0.30 today

52W Low $29.11High $50.79

Vol 0.27M · Avg 0.51M

EPS (TTM)$2.34

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+18.71%

Period High

$49.84

Period Low

$29.18

Latest

$34.64

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dynavax Technologies Corporation

DVAX

$1.82B

Pulse Biosciences, Inc.

NASDAQ:PLSE

$1.69B

Innoviva, Inc.

NASDAQ:INVA

$1.68B

Atai Beckley Inc.

NASDAQ:ATAI

$1.44B

Nektar Therapeutics

NASDAQ:NKTR

$1.16B

Cronos Group Inc.

NASDAQ:CRON

$1.00B

GoodRx Holdings, Inc.

NASDAQ:GDRX

$918.57M

Pacira BioSciences, Inc.

NASDAQ:PCRX

$904.31M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$885.83M

MiMedx Group, Inc.

NASDAQ:MDXG

$536.20M

What is the latest COLL filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does COLL have?

Intrinsic Alpha currently shows 20 recent filings for COLL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.